Section Arrow
NLSP.NASDAQ
- NLS Pharmaceutics Ltd
(Financial Status)
Quotes are at least 15-min delayed:2024/05/16 06:09 EDT
Last
 0.146
-0.0049 (-3.25%)
Day High 
0.151 
Prev. Close
0.1509 
1-M High
0.1579 
Volume 
50.21K 
Bid
0.1351
Ask
0.146
Day Low
0.1339 
Open
0.151 
1-M Low
0.113 
Market Cap 
6.54M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.14 
20-SMA 0.14 
50-SMA 0.19 
52-W High 1.53 
52-W Low 0.113 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.50/-0.45
Enterprise Value
6.85M
Balance Sheet
Book Value Per Share
-0.10
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed:2024/05/16 06:09 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.